Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Home Halo Kicks Off Franchise Push With 10–15 Location Goal In First Year
Home Halo, a non‑medical home‑care provider, is entering franchising with a goal of opening 10‑15 locations in the next year and scaling to 20‑30 new sites annually thereafter. The company’s first franchisee controls twelve territories in eastern Massachusetts, using a refined operating model tested since September. Home Halo supports franchisees with a 160‑step launch checklist and is investing heavily in brand awareness through SEO and social media. The firm is also evaluating Medicaid reimbursement to diversify its payer mix as it expands nationally.
Blackstone Closes Record $6.3B Life Sciences Fund: Institutional Capital Floods the Healthcare:
Blackstone announced the final close of its BXLS VI fund at a record $6.3 billion, making it the largest private‑capital vehicle devoted solely to life sciences. The fund was oversubscribed, ending roughly 40% larger than its predecessor, reflecting a surge of institutional...
Colon Cancer Screenings: When To Start
Colorectal cancer diagnoses are rising among adults under 50, prompting a shift in screening recommendations. The U.S. Preventive Services Task Force now advises average‑risk individuals to begin colonoscopy screening at age 45, down from 50. High‑risk patients—those with symptoms, family...
Low Sick Pay Is Making Britain Sicker
The UK’s statutory sick pay (SSP) remains at £118.75 a week (about $150), one of the lowest among advanced economies. Despite new legislation eliminating the three‑day unpaid waiting period and extending coverage to part‑time and low‑wage workers, the rate has...
:max_bytes(150000):strip_icc():format(jpeg)/paxil-withdrawal-symptoms-timeline-and-treatment-4769771_final-211352c6264747e2bb82f427757f8adf.png)
How Long Does Withdrawal From Paxil Last?
Paxil (paroxetine), a short‑acting SSRI, often triggers withdrawal symptoms within two to three days of dose reduction, with effects lasting up to six weeks or longer. Over half of antidepressant discontinuers report such symptoms, including nausea, dizziness, vivid dreams, anxiety,...
Diagnosed With Pancreatic Cancer: Now What?
Pancreatic cancer’s five‑year survival sits at just 13%, making early, expert care essential. The University of Michigan Rogel and Blondy Center emphasizes a multidisciplinary, high‑volume approach that includes surgeons, oncologists, dietitians, and palliative specialists. Patients are urged to seek centers...
Australian Government Rolls Out Free Medicare Mental Health Check‑In Service Nationwide
The Australian Government Department of Health has launched Medicare Mental Health Check‑In, a free online service that provides low‑intensity cognitive‑behavioural therapy tools and optional telehealth practitioner support for people with mild mental‑health challenges, starting 30 May 2026. The initiative expands...
Multidisciplinary Care Redefines Obesity Treatment, Says Malaysian Endocrinologist
Dr Kiran Nair of ParkCity Medical Centre highlighted a growing move toward multidisciplinary obesity care during World Obesity Day, arguing that weight loss alone is insufficient. She stressed that obesity is a chronic disease requiring coordinated medical, psychological and lifestyle...
India’s ICMR‑NIN Wraps Up World’s Largest Nutrition‑Biomarker Survey of 260,000 People
The Indian Council of Medical Research’s National Institute of Nutrition has finished a two‑year survey of 2.6 lakh individuals in 183 districts, linking diet, activity and blood biomarkers. The dataset, called DABS‑I, is the first of its kind in India and...
Tirzepatide Cuts Cardiorenal Events 14% vs Dulaglutide in Landmark Trial
A post‑hoc analysis of the SURPASS‑CVOT trial finds the dual GLP‑1/GIP agonist tirzepatide lowers a broad six‑component cardiorenal endpoint by 14% compared with the GLP‑1‑only drug dulaglutide. The result, presented at ACC 2026, could reshape how biohackers approach metabolic health...
Aurinia to Acquire Kezar for $6.96 per Share, Adding Immunoproteasome Asset
Aurinia Pharmaceuticals announced a definitive agreement to acquire Kezar Life Sciences for $6.955 in cash per share plus a contingent value right (CVR). The deal, slated to close in Q2 2026, gives Aurinia access to Kezar’s lead immunoproteasome inhibitor, zetomipzomib, and...
CNBC Documentary Spotlights Value‑Based Care as Engine for Brain Health and $6 Trillion GDP Boost
The Catalight Group and a coalition of health, economic and policy leaders premiered a CNBC documentary that frames value‑based care as the linchpin for brain health and a $6.2 trillion boost to global GDP. The film cites staggering productivity losses and...
Right Through the Skull
Researchers have unveiled a novel calvarial delivery platform that injects drug‑laden nanoparticles into the skull’s bone marrow. Immune cells within the diploic space capture the particles and migrate across skull‑meninges channels, ferrying the therapeutic cargo into the brain. In mouse...
Missile Cancer Study Finds Increased Rate of Two Cancers Based on More Data
The U.S. Air Force School of Aerospace Medicine’s Missile Community Cancer Study, now analyzing 148,078 cases from 1976‑2010, found statistically higher rates of testicular cancer and Hodgkin lymphoma among intercontinental ballistic missile (ICBM) personnel compared with other Airmen. Earlier phases...
AI-Powered Stroke Tool Linked to Improved Patient Outcomes in Large Clinical Trial
A large cluster‑randomized trial of more than 21,000 acute ischemic‑stroke patients across 77 Chinese hospitals tested an AI‑powered clinical decision support system (CDSS). The tool, which combines AI‑assisted imaging with guideline‑based treatment prompts, lowered the 3‑month composite vascular‑event rate from...
NIH Awards Top Scientific Teams for Innovations Linking Nutrition and Autoimmune Disease
The National Institutes of Health announced 15 winning teams in its Nutrition for Our Immune System Health (NOURISH) Autoimmunity Challenge, each receiving a $10,000 prize. The challenge solicited scalable, patient‑centered ideas that integrate diet, microbiome, and multi‑omics approaches to study...
Canada Unveils First Brain‑Heart‑Mental Health Guideline, Merging Cardiac and Neurologic Care
The University of Ottawa Heart Institute has published an 11‑point clinical practice guideline that integrates cardiovascular, neurological and mental‑health care. The C‑CHANGE/CMAJ guideline aims to replace siloed disease protocols with a patient‑centred, whole‑person approach, and it is already being rolled...
Doctors Warn Shallow Breathing Undermines Brain, Heart and Fuels Anxiety
Indian pulmonologists led by Dr. Sushil Gupta warn that chronic shallow breathing activates stress pathways, reduces focus and can cause cardiac arrhythmia. The warning comes as breath‑focused meditation apps see a surge in users seeking quick relief.
Study Shows 11‑Minute Sleep Boost Cuts Heart Risk by 10%
Researchers tracking 53,000 adults over eight years discovered that sleeping an extra 11 minutes each night, combined with modest increases in activity and vegetable intake, reduces the risk of heart attacks, stroke and heart failure by 10%. The findings give...
Immune Modulation Preps FDA Submission for Parkinson's Drug After 30‑Year Journey
Immune Modulation, Inc. announced it is finalizing pre‑IND toxicology and pharmacokinetic studies to file an FDA submission for hypoestoxide, a plant‑derived anti‑inflammatory candidate for Parkinson's disease. The move caps a 30‑year scientific trek that began with a rainforest compound identified...
United Therapeutics Shares Surge 12% on Positive TETON-1 Phase III Results
United Therapeutics reported that its TETON-1 Phase III trial met the primary endpoint, delivering a 130.1 mL improvement in forced vital capacity for idiopathic pulmonary fibrosis patients. The news lifted the stock more than 12% and set the company on a path...
Neurolief Secures $6 Million Investment After FDA Clears First At‑Home Brain Neuromodulation Therapy
Neurolief announced a $6 million milestone‑based investment from BrainsWay Ltd. following the FDA’s Premarket Approval of its Proliv™Rx at‑home brain neuromodulation system. The clearance marks the first prescription‑grade, home‑use device for adults whose depression has not responded to at least one...
Cheshire Deploys GoldCare to Strengthen Consumer Independence
Cheshire Independent Living Services in London, Ontario has rolled out GoldCare’s integrated healthcare software, including a consumer portal that offers real‑time access to personal attendant schedules. The portal empowers consumers and families with direct visibility, enhancing autonomy and reducing reliance...
Standardizing Health Data for Good Medicine and Connected Care
On March 31 2026 the Canadian Institute for Health Information released Version 2 of the Canadian Core Data for Interoperability (CACDI), a national standard that defines core patient, clinical, and provider data for seamless exchange. Co‑designed with patients, clinicians, Indigenous groups and digital‑health...
Hypercare Mobilizes Vascular Team During ‘Life and Limb’ Emergencies
Royal Victoria Regional Health Centre in Barrie completed a one‑year pilot of Hypercare for its Vascular Life and Limb emergency pathway. The platform replaced individual phone calls with a single‑tap, secure group alert, cutting hospital acceptance time from 15 minutes...
Medly Heart Monitoring Enters Commercialization Through Vitall
Medly, a smartphone‑based remote monitoring system for heart‑failure patients developed by Toronto’s University Health Network, is now being commercialized by Vitall Intelligence. The platform gathers weight, blood pressure and heart‑rate data via Bluetooth devices and uses an algorithm to flag...
Boner Bears Honey May Be Harmful Due to Hidden Drug Ingredients
The FDA has warned consumers to avoid Boner Bears Honey, a sexual‑enhancement honey sold online and in some stores, after laboratory tests revealed it contains undeclared sildenafil and tadalafil. The product was identified during an inspection of Pure Vitamins and...
Neurosurgeons at St. Michael’s Use Low-Field MRI to Assist Surgeries
Neurosurgeons at Toronto’s St. Michael’s Hospital have begun using the Hyperfine Swoop® low‑field MRI scanner inside the operating room to obtain immediate post‑resection images. The portable 0.064‑tesla device can be wheeled into the suite, allowing scans within minutes while surgeons...
University of Ottawa Launches New Applied AI Centre for Healthcare
The University of Ottawa has inaugurated the Ottawa Medical Artificial Intelligence Research Institute (OMARI), an applied‑research hub embedded in its Faculty of Medicine and linked to the city’s six hospitals. Led by AI expert Dr. Khaled El Emam, OMARI aims to...
Imunon Inc (IMNN) Q4 2025 Earnings Call Transcript
Imunon reported Q3 2025 results, highlighting $5.3 million cash and a runway extending to mid‑Q1 2026 after a $4.5 million equity raise. Operating expenses fell 31% year‑over‑year, reducing monthly burn to $1.25‑$1.5 million. The pivotal OVATION 3 phase III ovarian‑cancer trial enrolled nine patients, surpassing internal targets,...
Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Transcript
OrthoPediatrics Corp. reported fourth‑quarter 2025 revenue of $61.6 million, a 17% year‑over‑year increase driven by strong performance across trauma, deformity, scoliosis and specialty bracing segments. The quarter marked the company’s first positive free‑cash‑flow generation, delivering $10 million, while adjusted EBITDA rose 59%...
Omeros Corp (OMER) Q4 2025 Earnings Call Transcript
Omeros Corp reported a Q3 2025 net loss of $30.9 million, but secured a transformative agreement with Novo Nordisk that could deliver up to $2.1 billion in upfront and milestone payments. The $240 million upfront cash will retire most short‑term debt and fund more...
Kairos Pharma Ltd (KAPA) Q4 2025 Earnings Call Transcript
Karyopharm Therapeutics posted Q4 2025 revenue of $34.1 million, an 11.8% year‑over‑year increase, while total 2025 revenue reached $146.1 million. Operating efficiency improved, with R&D and SG&A expenses down 17% and 16% respectively, yet the company recorded a GAAP net loss of...
Bioatla Inc (BCAB) Q4 2025 Earnings Call Transcript
BioAtla reported that it is in the final stages of a strategic partnership transaction expected to close by year‑end and disclosed FDA alignment on the phase‑3 design of its OSFI (OSV) trial for second‑line oropharyngeal squamous cell carcinoma. The trial...
Centessa Pharmaceuticals PLC (CNTA) Q4 2025 Earnings Call Transcript
Centene reported full‑year 2025 adjusted diluted EPS of $2.08, while Q4 showed a $(1.19) loss driven by a $389 million divestiture charge. Management guided 2026 adjusted EPS above $3, implying more than 40% year‑over‑year growth, anchored by Medicaid margin stabilization and...
Mink Therapeutics Inc (INKT) Q4 2025 Earnings Call Transcript
MiNK Therapeutics reported a cash position of $14.3 million, extended through 2026 after a $1.2 million raise, while posting a $2.9 million net loss for Q4. Clinical data showed AGENT‑797 combined with PD‑1 achieved a median overall survival of roughly 23 months in heavily...
Monday March 30, 2026
The medical device landscape is accelerating across multiple fronts. Medtronic secured FDA clearance to extend its robotic platform into cranial and ENT surgeries, while Boston Scientific introduced a fluid‑management system for ureteroscopy. At‑home neuromodulation received a $6 million infusion after FDA...
The Cut's False Article on Cornell Hospital Faces Backlash
So @TheCut wrote a hit piece on the @WeillCornell Alexandra Cohen hospital and of course it’s not true and worse they used photos of people who had great deliveries and some who didn’t even have a baby there. The comments...
Vietnam: AI for Early Detection of Non-Communicable Diseases
Vietnam is fast‑tracking AI integration into its healthcare system to improve early detection of non‑communicable diseases such as cancer, cardiovascular disease, diabetes and chronic respiratory illnesses. The government and hospitals are expanding electronic health records and centralised data platforms, enabling...
Emergency Visits Rise, Revealing AI’s Cautious Triage Gaps
Interesting. I’m surprised the graph doesn’t show those who decided self care or no care. Also interesting that emergency visits went up. Maybe that’s good? They uncovered conditions that need higher level of care? Or the AI is being cautious.
Cancer Advances Offer Hope Amid Personal Loss
My father (and a dear friend's father) both died of this form of cancer. It is great to see the advances in cancer treatment... which will only be accelerated in the coming years (provided the luddites don't win the...
Digital Curbside Consults Having Big Impact in Rural Maine
The Community Care Partnership of Maine (CCPM) has rolled out the PicassoMD digital curbside consult platform across its 22 member clinics, linking primary‑care providers with specialists in seconds. Since its October 2023 launch, more than 300 clinicians have completed over 5,700...
Improving Connecticut’s Public Health Through Cross-Sector Data-Sharing
Connecticut’s Prevention Data Portal, launched in 2018, showcases how cross‑sector data sharing can improve public‑health outcomes without massive new infrastructure investments. The portal aggregates local, state, and federal datasets, delivering free epidemiological profiles, data stories, and infographics on mental health,...
Flu Hospitalizations in Nursing Homes Reduced by Quick, Widespread Preventive Antiviral Treatment
A JAMA Internal Medicine study of 404 influenza outbreaks in U.S. nursing homes found that administering the antiviral oseltamivir to at least 70% of residents within two days sharply reduced 14‑day hospitalizations. The retrospective cohort covered over 35,000 resident observations...
Irregular Bedtime Doubles Cardiac Risk
Midlife adults with irregular bedtimes face twice the risk of major cardiovascular events when they also sleep less than eight hours, according to a decade‑long Finnish cohort of 3,231 participants. The study, which used activity‑tracker data to measure sleep timing,...
The BioPharm Brief: Talking Lifecycle Optimization, Strategic Investment, and Collaboration Shaping Growth Trajectory
The FDA has approved a higher-dose regimen of nusinersen (Spinraza) for spinal muscular atrophy, aiming to boost drug exposure and improve long‑term motor function. The approval underscores a broader industry shift toward lifecycle optimization of RNA‑targeted therapies. Simultaneously, biopharma firms...
Beth Israel Lahey Hospital President to Retire; Successor Named
Jonathan Lind has been appointed president of Beth Israel Deaconess Hospital‑Plymouth, effective May 4, succeeding retiring leader Kevin Coughlin. Lind previously served as president of Swedish Hospital in Chicago, where he drove ambulatory growth and achieved the highest employee‑engagement scores across...
‘The Pitt’ Shows Burnout Is A System Failure, Not A Personal One
The TV drama “The Pitt” highlighted systemic burnout in emergency medicine, showing a medical student leaving her shift despite a busy ER. Data cited in the episode reveal that roughly 60% of emergency‑room physicians and 71% of public‑health workers report...
Most Hospital Revenue Is Not From Patient Care
A new Trilliant Health analysis shows that hospitals generate only about one‑third of their gross revenue from patient care, with a median of 29.9% in 2024. The share varies widely, from 8.3% to 86.6%, and is lower for for‑profit facilities...
FDA Suspends Medical Spa's Mammography Operations Amid 'Serious Concerns' About Quality
The U.S. Food and Drug Administration ordered the Greenbrier Clinic in Sulphur Springs, West Virginia, to suspend its mammography services after an American College of Radiology review flagged serious quality concerns. The FDA’s action covers exams performed between October 28, 2023 and...